Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA GLENMARK PHARMA SUN PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 43.2 -31.4 - View Chart
P/BV x 6.9 2.9 243.0% View Chart
Dividend Yield % 0.7 0.3 271.8%  

Financials

 SUN PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-23
GLENMARK PHARMA
Mar-23
SUN PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,072487 220.0%   
Low Rs790349 226.4%   
Sales per share (Unadj.) Rs182.9460.4 39.7%  
Earnings per share (Unadj.) Rs35.713.4 266.8%  
Cash flow per share (Unadj.) Rs46.235.0 131.9%  
Dividends per share (Unadj.) Rs11.502.50 460.0%  
Avg Dividend yield %1.20.6 206.6%  
Book value per share (Unadj.) Rs233.4335.1 69.6%  
Shares outstanding (eoy) m2,399.34282.17 850.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.10.9 560.5%   
Avg P/E ratio x26.131.3 83.5%  
P/CF ratio (eoy) x20.111.9 168.8%  
Price / Book Value ratio x4.01.2 319.8%  
Dividend payout %32.218.7 172.4%   
Avg Mkt Cap Rs m2,233,361117,953 1,893.4%   
No. of employees `000NANA-   
Total wages/salary Rs m82,96027,810 298.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m438,857129,901 337.8%  
Other income Rs m8,1993,168 258.8%   
Total revenues Rs m447,055133,069 336.0%   
Gross profit Rs m112,90015,125 746.4%  
Depreciation Rs m25,2946,113 413.8%   
Interest Rs m1,7203,496 49.2%   
Profit before tax Rs m94,0848,685 1,083.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,4764,911 172.6%   
Profit after tax Rs m85,6083,774 2,268.4%  
Gross profit margin %25.711.6 220.9%  
Effective tax rate %9.056.5 15.9%   
Net profit margin %19.52.9 671.4%  
BALANCE SHEET DATA
Current assets Rs m398,61998,737 403.7%   
Current liabilities Rs m199,06450,455 394.5%   
Net working cap to sales %45.537.2 122.3%  
Current ratio x2.02.0 102.3%  
Inventory Days Days1477 2,194.6%  
Debtors Days Days95115 82.6%  
Net fixed assets Rs m376,96076,920 490.1%   
Share capital Rs m2,399282 850.3%   
"Free" reserves Rs m557,55594,281 591.4%   
Net worth Rs m559,95494,563 592.1%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m775,794175,658 441.7%  
Interest coverage x55.73.5 1,598.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 76.5%   
Return on assets %11.34.1 272.0%  
Return on equity %15.34.0 383.1%  
Return on capital %17.19.2 186.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m154,05346,464 331.6%   
Fx outflow Rs m71,51112,712 562.5%   
Net fx Rs m82,54133,751 244.6%   
CASH FLOW
From Operations Rs m49,5936,254 793.0%  
From Investments Rs m-79,437-5,285 1,503.1%  
From Financial Activity Rs m23,761-775 -3,067.6%  
Net Cashflow Rs m1,155325 355.3%  

Share Holding

Indian Promoters % 54.5 46.7 116.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.6 34.7 105.5%  
FIIs % 17.1 23.7 72.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 53.4 85.3%  
Shareholders   612,626 209,931 291.8%  
Pledged promoter(s) holding % 2.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Sun Pharma vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sun Pharma vs Glenmark Pharma Share Price Performance

Period Sun Pharma Glenmark Pharma S&P BSE HEALTHCARE
1-Day 0.77% -0.57% 1.18%
1-Month 3.00% 5.16% -0.75%
1-Year 64.65% 112.94% 61.82%
3-Year CAGR 39.45% 27.51% 18.16%
5-Year CAGR 27.78% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Sun Pharma share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Sun Pharma hold a 54.5% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sun Pharma and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Sun Pharma paid a dividend of Rs 11.5 per share. This amounted to a Dividend Payout ratio of 32.2%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Sun Pharma, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.